Our mission is to change cancer into a chronic disease.

Athenex is a clinical stage biotechnology company focused on the development of autologous and allogeneic CAR-NKT cell therapies to treat cancers.  Our goal is to become a global leader in bringing innovative cancer treatments to the market and improving health outcomes of cancer patients.